E M H Swiss Medical Publishers Ltd

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Drilon
    Drilon
  3. Koche
    Koche
  4. Rosenberg
    Rosenberg
  5. Sherman
    Sherman
  6. Yang
    Yang
  7. Modi
    Modi
  8. Morris
    Morris
  9. Cercek Hanjis
    Cercek Hanjis
  10. Landau
    Landau

Groups

  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (14)
  3. Center for Hematologic Malignancies (13)
  4. Center for Molecular Imaging and Biotechnology (13)
  5. GSK Faculty (13)
  6. Executive Committee, Center for Hematologic Malignancies (12)
  7. Hematologic Malignancies, Division of (12)
  8. Adult Leukemia (11)
  9. Human Oncology and Pathogenesis Program (11)
  10. Genitourinary Oncology Service (5)
Search Within
Formats
  1. Meeting Abstract (27)
  2. Journal Article (2)
Groups
  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (14)
  3. Center for Hematologic Malignancies (13)
  4. Center for Molecular Imaging and Biotechnology (13)
  5. GSK Faculty (13)
  6. Executive Committee, Center for Hematologic Malignancies (12)

More Groups

People
  1. Ross Levine (11)
  2. Alexander Drilon (4)
  3. Eric Sherman (3)
  4. Jonathan Rosenberg (3)
  5. Li Yang (3)
  6. Richard Koche (3)

More People

Years
  1. 2023 (4)
  2. 2022 (7)
  3. 2021 (5)
  4. 2020 (8)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Swiss Medical Weekly (29)

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic resistance to the novel JAK2 inhibitor CHZ868 in MPN is dependent on MEK-ERK activation and is targetable
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Wicki, A.; Yang, J. L.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Levine, R. L.; Koche, R.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer (MTC)
    Meeting Abstract

    Shah, M.; Sherman, E.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J.; Worden, F.; Brose, M.; Leboulleux, S.; Godbert, Y.; more...
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small-cell lung cancer
    Meeting Abstract

    Goto, K.; Oxnard, G.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T.; Gainor, J.; McCoach, C.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Dual genetic targeting of ERK1 and ERK2 reduces the fitness of the malignant clone in myeloproliferative neoplasm mice
    Meeting Abstract

    Stivala, S.; Brkic, S.; Santopolo, A.; Dirnhofer, S.; Passweg, J. R.; Tsakiris, D.; Neel, B.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Genetic targeting of ERK1/ERK2 kinases impairs the fitness of the myeloproliferative neoplasm clone
    Meeting Abstract

    Stivala, S.; Brkic, S.; Dirnhofer, S.; Passweg, J. R.; Tsakiris, D. A.; Neel, B. G.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Resistance to type II JAK2 inhibition in MPN is dependent on targetable MAPK activation and is reversible
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Radimerski, T.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Dual JAK2 and ERK1/2 kinase inhibition as a potent corrective approach in myeloproliferative neoplasms
    Meeting Abstract

    Brkic, S.; Stivala, S.; Jungius, S.; Santopolo, A.; Passweg, J. R.; Tsakiris, D.; Radimerski, T.; Munck, J.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • ERK and MEK kinases as novel therapeutic targets in myeloproliferative neoplasms based on bypass MAPK pathway activation
    Meeting Abstract

    Stivala, S.; Baerenwaldt, A.; Codilupi, T.; Ghosh, N.; Hao-Shen, H.; Dirnhofer, S.; Dettmer, M. S.; Simillion, C.; Chiu, S.; Keller, M.; more...
    Swiss Medical Weekly (2018)

    Fulltext@MSK | Save
  • The CRISPR revolution and its impact on cancer research
    Journal Article

    Kannan, R.; Ventura, A.
    Swiss Medical Weekly (2015)

    Fulltext@MSK | Save

    • E M H Swiss Medical Publishers Ltd – authorized name for: